John Poyhonen Net Worth & Insider Trades

John Poyhonen - President & CCO, Heron Therapeutics, Inc

As of January 20, 2023

What is John Poyhonen's Net Worth?

The current estimated net worth of Heron Therapeutics, Inc's President & CCO, John Poyhonen, is estimated to be about $1.19M . John Poyhonen owns about 18,143 units of Heron Therapeutics, Inc common stock. In the last 9 years at Heron Therapeutics, Inc, John Poyhonen has sold an estimated value of $74.39K worth.

What is John Poyhonen's Past Insider Trading?

John Poyhonen's largest purchase order was 10,000 units , worth over $122K on January 23, 2017. In total, John Poyhonen has made about 24 transactions over 9 years of their time at Heron Therapeutics, Inc. John Poyhonen usually trades in December, with the busiest year in 2022 and 2021. The most recent transaction was a purchase order of 5,143 units , worth over $90K on October 4, 2019.

John Poyhonen

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was John Poyhonen's Salary in 2020?

As President & CCO of Heron Therapeutics, Inc, John Poyhonen has a total base salary of $513,935 . John Poyhonen received compensation valued at about $2,670,194 in 2020 after becoming President & CCO. The vast majority of their compensation came in the form of stock awards of $314,400 , other earnings, plans or compensations of $197,960 , other earnings, plans or compensations of $197,960 , and other compensation of $8,550 .

What is John Poyhonen's' Mailing Address?

  • Mailing address is 11088 N Torrey Pines Rd C/o Senomyx Inc La Jolla CA 92037 CA

Heron Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Barry Quart, Pharm.D. 2020 $676,838 $916,995 $364,991 $364,991 $21,084 $5,346,803
Barry Quart, Pharm.D. 2019 $638,991 - $306,715 $306,715 $8,400 $5,870,479
Barry Quart, Pharm.D. 2018 $614,414 - $552,973 $552,973 $8,250 $5,991,297
John Poyhonen 2020 $513,935 $314,400 $197,960 $197,960 $8,550 $2,670,194
John Poyhonen 2019 $216,731 - $90,751 $90,751 $6,219 $4,524,764
Kimberly Manhard 2020 $519,167 $314,400 $199,976 $199,976 $8,550 $2,196,457
Kimberly Manhard 2019 $490,136 - $196,054 $196,054 $8,400 $2,509,866
Kimberly Manhard 2018 $466,796 - $350,097 $350,097 $8,250 $2,430,363
David Szekeres 2020 $476,910 $314,400 $161,664 $161,664 $8,550 $2,462,197
Lisa Peraza 2020 $328,805 $138,855 $105,683 $105,683 $14,567 $1,578,739
Robert Hoffman 2020 $360,009 - - - $668,287 $1,028,296
Robert Hoffman 2019 $388,714 - $124,388 $124,388 $8,400 $2,034,232
Robert Hoffman 2018 $357,438 - $214,463 $214,463 $8,027 $1,719,634
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021020104/hrtx-def14a_20210617.htm

What are Heron Therapeutics, Inc's Past Insider Trades?

Heron Therapeutics, Inc's most recent insider trade came on May 4, 2022 by Kimberly Manhard who sold 1,504 units worth $7.15K . In the last 8 years, insiders at Heron Therapeutics, Inc have sold an estimated value of $130.38M and bought an estimated value of $66.83M worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Kimberly Manhard, EVP,  Barry D Quart, Chief Executive Officer,  and John Poyhonen, President & CCO .

HERON THERAPEUTICS, INC. /DE/ Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...